Cargando…
Antimonial Resistance in Leishmania donovani Is Associated with Increased In Vivo Parasite Burden
Leishmania donovani is an intracellular protozoan parasite that causes visceral leishmaniasis (VL). Antimonials (SSG) have long been the first-line treatment against VL, but have now been replaced by miltefosine (MIL) in the Indian subcontinent due to the emergence of SSG-resistance. Our previous st...
Autores principales: | Vanaerschot, Manu, De Doncker, Simonne, Rijal, Suman, Maes, Louis, Dujardin, Jean-Claude, Decuypere, Saskia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148249/ https://www.ncbi.nlm.nih.gov/pubmed/21829701 http://dx.doi.org/10.1371/journal.pone.0023120 |
Ejemplares similares
-
Linking In Vitro and In Vivo Survival of Clinical Leishmania donovani Strains
por: Vanaerschot, Manu, et al.
Publicado: (2010) -
Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex
por: Downing, Tim, et al.
Publicado: (2012) -
Relapse after Treatment with Miltefosine for Visceral Leishmaniasis Is Associated with Increased Infectivity of the Infecting Leishmania donovani Strain
por: Rai, Keshav, et al.
Publicado: (2013) -
Comparative Gene Expression Analysis throughout the Life Cycle of
Leishmania braziliensis: Diversity of Expression Profiles
among Clinical Isolates
por: Adaui, Vanessa, et al.
Publicado: (2011) -
Molecular Mechanisms of Drug Resistance in Natural Leishmania Populations Vary with Genetic Background
por: Decuypere, Saskia, et al.
Publicado: (2012)